Literature DB >> 9746374

The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis.

R French1, P Brocklehurst.   

Abstract

OBJECTIVE: To investigate the effect of pregnancy on disease progression and survival in women infected with HIV by a systematic review of the literature and meta-analysis.
METHODS: Appropriate publications were identified using electronic and hand searching of relevant journals from 1983 to 1996. Studies were included in the review if they were cohort studies, either prospective or retrospective, or case-control studies which investigated disease progression of pregnant women infected with HIV and included a control group of non-pregnant women infected with HIV for comparison. Methodological quality was assessed for each study. Data were extracted for predetermined outcome measures. Sensitivity analyses were performed to explore the association between pregnancy and disease progression for the following study characteristics: clinical setting (developed or developing countries), methodological quality (high or poor) and whether studies had controlled for potential confounding.
RESULTS: Seven studies, all prospective cohorts, were eligible to be included in the review. The summary odds ratio for the risk of an adverse maternal outcome related to HIV infection and pregnancy were as follows: death 1.8 (85% CI 0.99-3.3); HIV disease progression 1.41 (95% CI 0.85-2.33); progression to an AIDS-defining illness 1.63 (95% CI 1.00-2.67) and fall of CD4 cell count to below 200 x 10(6)/L 0.73 (95% CI 0.17-3.06). Sensitivity analyses showed that HIV progression in pregnancy was significantly more common in a developing country setting (odds ratio 3.71, 95% CI 1.82-7.75) than in developed countries (odds ratio 0.55, 95% 0.27-1.11) and also significantly more common in high quality studies when compared to low quality ones, odds ratios 3.71 (95% CI 1.82-7.57) and 0.55 (95% CI 0.27-1.11), respectively. However, there appears to be less progression of HIV disease and progression to AIDS when studies attempted to control for confounding by matching or restriction techniques, although this was not statistically significant in either case.
CONCLUSIONS: The findings of this review have implications for women infected with HIV who are pregnant or are considering a pregnancy. There does appear to be an association between adverse maternal outcomes and pregnancy in women infected with HIV, although this association is not strong. The relation may be due to the result of bias including residual confounding. Further large scale observational studies with long term follow up are required before this issue can be fully resolved.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Biology; Demographic Factors; Developed Countries; Developing Countries; Diseases; Hiv Infections; Immunity; Immunological Effects; Literature Review; Maternal Mortality; Mortality; Physiology; Population; Population Characteristics; Population Dynamics; Pregnancy; Pregnant Women; Reproduction; Research Methodology; Risk Factors; Viral Diseases

Mesh:

Year:  1998        PMID: 9746374     DOI: 10.1111/j.1471-0528.1998.tb10226.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  23 in total

1.  A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.

Authors:  Renee Heffron; Deborah Donnell; James Kiarie; Helen Rees; Kenneth Ngure; Nelly Mugo; Edwin Were; Connie Celum; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

2.  Effect of subsequent pregnancies on HIV disease progression among women in the Mulago Hospital MTCT-Plus program in Uganda.

Authors:  Dinah Amongin; Annettee Nakimuli; Robert Busingye; Mike Mubiru; Philippa Musoke; Twaha Mutyaba
Journal:  Int J Gynaecol Obstet       Date:  2015-12-31       Impact factor: 3.561

3.  Prevalent pregnancy, biological sex, and virologic response to antiretroviral therapy.

Authors:  Daniel Westreich; Denise Evans; Cindy Firnhaber; Pappie Majuba; Mhairi Maskew
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

4.  High Proportion of Deaths Attributable to HIV Among Postpartum Women in Botswana Despite Widespread Uptake of Antiretroviral Therapy.

Authors:  Rebecca Marie Zash; Sajini Souda; Jean Leidner; Kelebogile Binda; Chazha Hick; Kathleen Powis; Joseph Makhema; Mompati Mmalane; Max Essex; Shahin Lockman; Roger L Shapiro
Journal:  AIDS Patient Care STDS       Date:  2017-01       Impact factor: 5.078

5.  Older age at infection and nulliparity are associated with long-term non-progression in female sex workers infected with non-subtype B HIV-1.

Authors:  Vernon Mochache; Barbra A Richardson; Linnet N Masese; Susan M Graham; Kishorchandra Mandaliya; John Kinuthia; Walter Jaoko; Julie Overbaugh; R Scott McClelland
Journal:  Int J STD AIDS       Date:  2020-04-15       Impact factor: 1.359

6.  Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Authors:  Elizabeth M Stringer; Mark Giganti; Rosalind J Carter; Wafaa El-Sadr; Elaine J Abrams; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2009-11       Impact factor: 4.177

7.  Quality of systematic reviews of observational nontherapeutic studies.

Authors:  Tatyana Shamliyan; Robert L Kane; Stacy Jansen
Journal:  Prev Chronic Dis       Date:  2010-10-15       Impact factor: 2.830

8.  Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception.

Authors:  V Le Moing; A Taïeb; P Longuet; C Lewden; V Delcey; M C Thiebaut Drobacheff; G Chêne; C Leport
Journal:  HIV Med       Date:  2008-09-14       Impact factor: 3.180

Review 9.  Hormonal contraception and HIV disease progression.

Authors:  Elizabeth Stringer; Erik Antonsen
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

10.  HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods.

Authors:  Lynn T Matthews; Angela Kaida; Steven Kanters; Helen Byakwagamd; A Rain Mocello; Conrad Muzoora; Annet Kembabazi; Jessica E Haberer; Jeffrey N Martin; David R Bangsberg; Peter W Hunt
Journal:  AIDS       Date:  2013-10       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.